Al-Homaidhi A, Prince H M, Al-Zahrani H, Doucette D, Keating A
University of Toronto Autologous Blood and Marrow Transplant Program, The Toronto Hospital, Ontario, Canada.
Bone Marrow Transplant. 1998 Jan;21(2):209-14. doi: 10.1038/sj.bmt.1701036.
Bone marrow (BM) histiocystosis in association with the administration of granulocyte-macrophage colony-stimulating factor (GM-CSF) is a rare phenomenon with few published cases. We report two cases of BM histiocystosis in patients with Hodgkin's disease treated with GM-CSF after autologous bone marrow transplantation. Both patients also developed clinical features of capillary leak syndrome, another rare complication of GM-CSF administration. GM-CSF-induced histiocystosis should now be considered in the differential diagnosis of delayed engraftment post-autotransplant.